Logotype for Hydrofarm Holdings Group Inc

Hydrofarm Group (HYFM) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Hydrofarm Holdings Group Inc

Q3 2024 earnings summary

16 Jan, 2026

Executive summary

  • Net sales declined 18.8% year-over-year to $44.0 million in Q3 2024, primarily due to industry oversupply, retail closures, and pricing pressures, but the company remains on track to meet full-year guidance.

  • Gross profit margin improved to 19.4% from 6.1% year-over-year, driven by a higher mix of proprietary brands, lower restructuring costs, and effective cost-saving actions.

  • Net loss narrowed to $13.1 million ($0.29 per share) from $19.9 million ($0.44 per share) in the prior year, reflecting higher gross profit and lower SG&A expenses.

  • Continued diversification of revenue sources, with increased international and non-cannabis sales, and ongoing investment in proprietary brands.

  • Announced CEO transition effective January 2025, with the current CFO set to become CEO.

Financial highlights

  • Q3 2024 net sales were $44.0 million, down 18.8% year-over-year; nine-month net sales were $153.0 million, down 14.7% year-over-year.

  • Gross profit was $8.5 million (19.4% margin), up from $3.3 million (6.1%) last year; adjusted gross profit was $10.7 million (24.3%), up 130 basis points year-over-year.

  • SG&A expense was $17.6 million, down from $19.5 million last year; adjusted SG&A was $10.7 million, an 11% reduction year-over-year.

  • Net loss for Q3 2024 was $13.1 million, improved from $19.9 million year-over-year; nine-month net loss was $49.2 million, nearly flat versus prior year.

  • Cash balance at quarter-end was $24.4 million, with $128 million in total debt and $41 million in total liquidity.

Outlook and guidance

  • Reaffirmed full-year 2024 guidance for net sales, adjusted EBITDA, and positive free cash flow.

  • Net sales expected to decline in the low- to high-teens percent range year-over-year, tracking mid-range.

  • Capital expenditures for 2024 expected to be $2.5–$3.5 million, lowered from prior guidance.

  • Management expects annual cost savings of over $2.0 million from restructuring and asset sale actions.

  • Confident in long-term business potential and positioned for growth when industry demand returns.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more